Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased by a...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Expanding the Discussion on Pneumocystis jirovecii Pneumonia Prophylaxis in Non-HIV Immunocompromised Adults.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Clinical Characteristics and Outcomes of Cytomegalovirus DNAemia in Non-HIV-Infected and Non-Transplant Patients: A Propensity Score-Matched Analysis.

Pathogens (Basel, Switzerland)·2026
Same author

Updates on Chromoblastomycosis: Evolving Insights in Clinical Management and Therapeutic Strategies.

Current fungal infection reports·2026
Same author

<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV, Non-HCT Adults: Real-World Patterns of Overlapping Immunosuppression and PJP-Active Therapy.

The Annals of pharmacotherapy·2026
Same author

Heart Failure Incidence and Risk Factors in U.S. Adults Receiving Bezlotoxumab: A Large Database Analysis.

Infectious disease reports·2026
Same author

Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA.

EClinicalMedicine·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jun 7, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA

Published on: July 15, 2011

27.8K

La lepra

Nelson Iván Agudelo Higuita1, Charlotte Avanzi2, Andrés F Henao-Martínez3

  • 1Department of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, USA; Instituto de Enfermedades Infecciosas y Parasitología Antonio Vidal, Tegucigalpa, Honduras.

Lancet (London, England)
|January 23, 2026
PubMed
Resumen
Este resumen es generado por máquina.

La lepra, o enfermedad de Hansen, es una infección bacteriana curable que afecta a las comunidades empobrecidas. Abordar los factores diagnósticos, preventivos y socioeconómicos es crucial para su eliminación global y reducir el estigma asociado.

Videos de Experimentos Relacionados

Last Updated: Jun 7, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA

Published on: July 15, 2011

27.8K

Área de la Ciencia:

  • Enfermedades infecciosas
  • Salud pública
  • Dermatología

Sus antecedentes:

  • La lepra (enfermedad de Hansen) es una enfermedad granulomatosa curable causada por Mycobacterium leprae / lepromatosis.
  • Afecta desproporcionadamente a las poblaciones empobrecidas, lo que lleva a una discapacidad significativa, desfiguración y estigma social.
  • El tropismo bacteriano se dirige a las células dérmicas, endoteliales y de Schwann, causando daños extensos en los nervios y la piel.

Objetivo del estudio:

  • Para proporcionar una visión actualizada de la lepra.
  • Resaltar aspectos clave de salud pública y clínicos de la enfermedad.

Principales métodos:

  • Este seminario sintetiza el conocimiento actual sobre la lepra.
  • Se examinan los retos en el diagnóstico, la prevención y los factores socioeconómicos.

Principales resultados:

  • La eliminación de la lepra se ve obstaculizada por la falta de diagnósticos sensibles.
  • Las intervenciones preventivas subóptimas y el estigma persistente siguen siendo obstáculos importantes.
  • El hecho de no abordar los factores de riesgo socioeconómicos y demográficos obstaculiza el progreso.

Conclusiones:

  • La lepra sigue siendo un desafío significativo para la salud mundial, especialmente para las poblaciones vulnerables.
  • Se necesitan estrategias integradas y sostenibles para una prevención y un control eficaces.
  • Abordar el estigma y los determinantes socioeconómicos es vital para la eliminación de la enfermedad.